| Therapeutic vaccines in renal cell carcinoma - Abstract - UroToday |
|
|
UroToday Metastatic renal cell carcinoma (mRCC) is a lethal disease. The advent of tyrosine kinase inhibitors (TKIs) has changed the disease process, yet the majority of patients will develop treatment-resistant disease. IL-2 based immunotherapy in mRCC is the |